Literature DB >> 2194960

Opsonic activity of cerebrospinal fluid in experimental cryptococcal meningitis.

M M Hobbs1, J R Perfect, D L Granger, D T Durack.   

Abstract

The role of antibody in protection against infection with Cryptococcus neoformans is undefined. In this paper we describe the development of opsonic activity in the cerebrospinal fluid (CSF) of rabbits in response to cryptococcal meningitis. The opsonin appeared to be immunoglobulin G (IgG); the activity was heat stable, copurified with the IgG fraction during protein A separation, and could be absorbed by encapsulated cryptococci. Immunosuppression with cyclosporine could be administered to prevent or allow in vivo deposition of IgG on the polysaccharide capsule of yeast in the CSF. Both early and late cyclosporine regimens resulted in prolonged, severe meningeal infections corresponding to the complete absence of in vitro opsonic activity in the CSF. While the production of opsonic antibody is part of the successful host response against C. neoformans in the central nervous system of rabbits, the presence of specific immunoglobulin by itself is insufficient for complete protection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2194960      PMCID: PMC258784          DOI: 10.1128/iai.58.7.2115-2119.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Cyclosporin A: an immunosuppressive agent preferentially active against proliferating T cells.

Authors:  D J White; A M Plumb; G Pawelec; G Brons
Journal:  Transplantation       Date:  1979-01       Impact factor: 4.939

2.  Cell-mediated immunity in Cryptococcosis.

Authors:  J R Graybill; R H Alford
Journal:  Cell Immunol       Date:  1974-10       Impact factor: 4.868

3.  Passively-acquired immunity in experimental cryptococcosis.

Authors:  D B Louria; T Kaminski
Journal:  Sabouraudia       Date:  1965-06

4.  Prognostic factors in cryptococcal meningitis. A study in 111 cases.

Authors:  R D Diamond; J E Bennett
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

5.  Cerebrospinal fluid macrophage response to experimental cryptococcal meningitis: relationship between in vivo and in vitro measurements of cytotoxicity.

Authors:  J R Perfect; M M Hobbs; D L Granger; D T Durack
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

6.  Nature of the effector cells responsible for antibody-dependent cell-mediated killing of Cryptococcus neoformans.

Authors:  R D Diamond; A C Allison
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

7.  Response of congenitally athymic (nude) and phenotypically normal mice to Cryptococcus neoformans infection.

Authors:  L K Cauley; J W Murphy
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

8.  Effects of the new anti-lymphocytic peptide cyclosporin A in animals.

Authors:  J F Borel; C Feurer; C Magnée; H Stähelin
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

9.  Host defense in cryptococcosis. I. An in vivo model for evaluating immune response.

Authors:  J R Graybill; R L Taylor
Journal:  Int Arch Allergy Appl Immunol       Date:  1978

10.  Chronic cryptococcal meningitis: a new experimental model in rabbits.

Authors:  J R Perfect; S D Lang; D T Durack
Journal:  Am J Pathol       Date:  1980-10       Impact factor: 4.307

View more
  7 in total

Review 1.  Antibody immunity and invasive fungal infections.

Authors:  A Casadevall
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

2.  Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity.

Authors:  S J Devi; R Schneerson; W Egan; T J Ulrich; D Bryla; J B Robbins; J E Bennett
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

3.  Opsonization of Cryptococcus neoformans by human anticryptococcal glucuronoxylomannan antibodies.

Authors:  Z Zhong; L A Pirofski
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

4.  A 77-kilodalton protein of Cryptococcus neoformans, a member of the heat shock protein 70 family, is a major antigen detected in the sera of mice with pulmonary cryptococcosis.

Authors:  H Kakeya; H Udono; N Ikuno; Y Yamamoto; K Mitsutake; T Miyazaki; K Tomono; H Koga; T Tashiro; E Nakayama; S Kohno
Journal:  Infect Immun       Date:  1997-05       Impact factor: 3.441

5.  Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection.

Authors:  J Mukherjee; L A Pirofski; M D Scharff; A Casadevall
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

6.  Cryptococcus neoformans fails to induce nitric oxide synthase in primed murine macrophage-like cells.

Authors:  P K Naslund; W C Miller; D L Granger
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

7.  Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice.

Authors:  S Mukherjee; S Lee; J Mukherjee; M D Scharff; A Casadevall
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.